BEONE MEDICINES LTD. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
BEONE MEDICINES LTD. (ONC) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $15.55 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-02-26
- BEONE MEDICINES LTD. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-09-30 was $15.55M.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month |
|---|---|---|
| 2025-09-30 | $15.55M 10-Q · filed 2025-11-06 | $15.55M 10-K · filed 2026-02-26 |